多元干预措施和技术,以减少脆弱,功能和认知衰退的负担:来自Age-It研究计划的见解
Chukwuma Okoye1,2, Luca Cuffaro1, Federico Emanuele Pozzi1,3
1School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
概括
这项研究评估了技术辅助干预措施,以预防老年人的脆弱性和认知衰退. 研究结果旨在改善护理模式,并在各种环境中促进健康老龄化.
科学领域:
- 老年学和公共卫生
- 数字健康干预措施 数字健康干预措施
- 衰老研究研究 衰老研究
背景情况:
- 与年龄相关的并发症对医疗保健系统构成重大挑战.
- 虚弱和功能/认知能力下降会影响老年人的生活质量.
- 该计划的重点是为健康老龄化提供创新解决方案.
研究的目的:
- 评估可扩展的,多组件的,技术辅助的干预措施,以预防老年人的脆弱性和减轻老年人的衰退.
- 评估社区,医院和长期护理机构的干预措施.
- 为了产生关于这些干预措施的有效性,可行性和成本效益的证据.
主要方法:
- 在不同的护理环境 (社区,医院,长期护理) 中进行了三项临床研究.
- 身体,认知,营养和心理社会组成部分的整合.
- 利用数字工具,衰老的生物标志物和一个集中的数据平台.
主要成果:
- 在现实环境中对多领域干预有效性的证据生成.
- 技术辅助的策略 (可穿戴设备,数字工具) 可能会改善坚持并使个性化护理成为可能.
- 整合人工智能以加强风险分层和早期识别受益于干预措施的个人.
结论:
- 支持向老年人的综合,公平的护理模式转变.
- 提供与政策相关的策略,以应对脆弱性和功能衰退.
- 为意大利和全球重新设计老年护理提供了洞察力.
更多相关视频
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
17.0K
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.6K
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Aging
561
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
561
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
